ConductScience.org, home

Paper40697997

Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study.

Gianfagna F and 15 others. Front Cardiovasc Med, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study. Papers, record 40697997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40697997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-07-25
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gianfagna FFrancesco
2Poli SSimone
3Costanzo SSimona
4Di Castelnuovo AAugusto
5Panzera TTeresa
6De Curtis AAmalia
7Magnacca SSara
8Persichillo MMariarosaria
9De Santi LLorenzo
10Cristofani CClaudia
11Loffredo DDaniele
12Cerletti CChiara
13Donati MBMaria Benedetta
14de Gaetano GGiovanni
15Iacoviello LLicia
16Moli-sani Study InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115188938Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.Clin Cardiol2004https://conductscience.org/library/papers/15188938PubMed
22476992Transient changes of serum lipoprotein(a) as an acute phase protein.Atherosclerosis1989https://conductscience.org/library/papers/2476992PubMed
312633762
Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease.
Clin Biochem2003https://conductscience.org/library/papers/12633762PubMed
428183512A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.J Am Coll Cardiol2017https://conductscience.org/library/papers/28183512PubMed
535606072Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?Atherosclerosis2022https://conductscience.org/library/papers/35606072PubMed
639219855Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk.Eur Heart J Open2024https://conductscience.org/library/papers/39219855PubMed
716000355Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.N Engl J Med2005https://conductscience.org/library/papers/16000355PubMed
839018080Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.JAMA Cardiol2024https://conductscience.org/library/papers/39018080PubMed
99799757Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.Clin Chem1998https://conductscience.org/library/papers/9799757PubMed
1030316749Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal.J Clin Lipidol2018https://conductscience.org/library/papers/30316749PubMed
1136764050Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.Atherosclerosis2023https://conductscience.org/library/papers/36764050PubMed
127660402Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.Stroke1995https://conductscience.org/library/papers/7660402PubMed
1320032323Genetic variants associated with Lp(a) lipoprotein level and coronary disease.N Engl J Med2009https://conductscience.org/library/papers/20032323PubMed
1430527993Interaction between Mediterranean diet and statins on mortality risk in patients with cardiovascular disease: Findings from the Moli-sani Study.Int J Cardiol2019https://conductscience.org/library/papers/30527993PubMed
1527677946Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.J Lipid Res2016https://conductscience.org/library/papers/27677946PubMed
1612826634Adherence to a Mediterranean diet and survival in a Greek population.N Engl J Med2003https://conductscience.org/library/papers/12826634PubMed
1723973688
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
J Am Coll Cardiol2013https://conductscience.org/library/papers/23973688PubMed
1838240386C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.Eur Heart J2024https://conductscience.org/library/papers/38240386PubMed
1936770634Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.Molecules2023https://conductscience.org/library/papers/36770634PubMed
2022898069Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.J Am Coll Cardiol2012https://conductscience.org/library/papers/22898069PubMed

See all 39 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42780648Identifying barriers to lipoprotein(a) testing in secondary cardiovascular prevention and co-designing implementation strategies: an Italian behavior change wheel-informed study.Front Cardiovasc Med2026https://conductscience.org/library/papers/42780648PubMed
42764843Lipoprotein(a) as a Predictor of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies (2016-2026).Cureus2026https://conductscience.org/library/papers/42764843PubMed
42643372Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies.Front Med (Lausanne)2026https://conductscience.org/library/papers/42643372PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LPA4018PubTator's text mininghttps://conductscience.org/library/genes/4018

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40697997

GET https://conductscience.org/api/papers/v1/40697997/references?page=2